HRT Financial’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

HRT Financial’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43,621	Closed	-$13K	–	3415
2023 Q2	$13K	Buy	43,621 +33,132	+316%	+$9.99K	﹤0.01%	2156
2023 Q1	$4K	Buy	+10,489	New	+$8.05K	﹤0.01%	2319
2022 Q3	–	Sell	-71,114	Closed	-$157K	–	3748
2022 Q2	$157K	Buy	+71,114	New	+$493K	﹤0.01%	2323

HRT Financial's GRNA Position: Q3 2023 in Review

HRT Financial sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 43,621 shares — an estimated $13K sold.

HRT Financial first reported a position in GRNA in Q2 2022 and held it in 3 quarters. The position peaked at $157K in Q2 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

HRT Financial reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 43,621 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $13K.
HRT Financial first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 3 quarters.
HRT Financial's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $157K in Q2 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.